Utility of radiolabeled somatostatin receptor analogues for staging/restaging and treatment of somatostatin receptor-positive pediatric tumors.
about
G-protein coupled receptor expression patterns delineate medulloblastoma subgroupsExpressions of Somatostatin Receptor Subtypes (SSTR-1, 2, 3, 4 and 5) in Neuroblastic Tumors; Special Reference to Clinicopathological Correlations with International Neuroblastoma Pathology Classification and Outcomes.Yttrium-90 DOTATOC therapy in GEP-NET and other SST2 expressing tumors: a selected review.Virotherapy of neuroendocrine tumors.Investigation of cancer cell lines for peptide receptor-targeted drug development.Somatostatin receptor subtype 2 (sst₂) is a potential prognostic marker and a therapeutic target in medulloblastoma.
P2860
Utility of radiolabeled somatostatin receptor analogues for staging/restaging and treatment of somatostatin receptor-positive pediatric tumors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Utility of radiolabeled somato ...... tor-positive pediatric tumors.
@en
Utility of radiolabeled somato ...... tor-positive pediatric tumors.
@nl
type
label
Utility of radiolabeled somato ...... tor-positive pediatric tumors.
@en
Utility of radiolabeled somato ...... tor-positive pediatric tumors.
@nl
prefLabel
Utility of radiolabeled somato ...... tor-positive pediatric tumors.
@en
Utility of radiolabeled somato ...... tor-positive pediatric tumors.
@nl
P50
P1433
P1476
Utility of radiolabeled somato ...... tor-positive pediatric tumors.
@en
P2093
Geetika Khanna
P304
P356
10.1634/THEONCOLOGIST.2007-0175
P577
2008-04-01T00:00:00Z